Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Upside Biotechnologies logo — Creating advanced regenerative solutions for severe burns wi...

Upside Biotechnologies

Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and superior handling.

Founded 2016 Series A Total: $2.30M Biotechnology, Health and Wellness +1

General Information

Company Name Upside Biotechnologies
Founded Year 2016
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

Get notified when Upside Biotechnologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Upside Biotechnologies

Upside Biotechnologies is a company that focuses on creating advanced regenerative solutions for severe burns. The company's slogan, "Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and superior handling," encapsulates their mission. Founded in 2016, Upside is at the forefront of developing the most effective treatment for severe burns. Their product offers a regenerative medicine solution by utilizing a small sample of healthy patient skin, which is then grown into differentiated, graftable skin to cover the burns. Notably, the advantages of Upside's engineered skin include faster production compared to any competitor's product, larger sheet sizes, and excellent handling characteristics. Upside Biotechnologies operates in the industries of Biotechnology, Health and Wellness, and Pharmaceutical. In 21 March 2017, the company received a NZD2.30M Series A investment from a consortium of investors, including Icehouse Ventures, Ice Angels, Tuhua Fund, New Zealand Venture Investment Fund, Cure Kids Ventures, and University of Auckland Inventors Fund. This investment signifies the confidence that prominent venture capital firms have in Upside's innovative approach to addressing the limitations of current severe burns treatments. Additionally, Upside holds intellectual property rights over the processes that provide these specific benefits, positioning the company as a key player in the regenerative medicine space.

Taxonomy: Regenerative Medicine, Severe Burns, Skin Grafting, Advanced Medical Solutions, Intellectual Property, Medical Innovation, Tissue Engineering, Regenerative Solutions, Burn Treatment, Medical Technology, Skin Regeneration, Bioengineering, Medical Research, Healthcare Innovations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		21 Mar 2017

Upside Biotechnologies Alternatives & Competitors

Upside Biotechnologies vs
CUTISS AG
CUTISS AG Switzerland

FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company

Series C
61 employees
Biotechnology, Health Care
Upside Biotechnologies vs
PharmaDerm
PharmaDerm

Pioneering new treatments for skin disorders, chronic wounds, severe burns, and dermatology since 20...

501-1000 employees
Biotechnology
Upside Biotechnologies vs
REGENERYS LIMITED
REGENERYS LIMITED

Pioneering regenerative medicine for improved healing and cosmetic outcomes.

Series Unknown
3 employees
Biotechnology, Health Care

FAQ About Upside Biotechnologies

Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and superior handling.
Upside Biotechnologies was founded in 2016.
Upside Biotechnologies operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Upside Biotechnologies has completed 1 funding round, raising a total of $2.30M. The latest funding stage is Series A.
Top alternatives and competitors to Upside Biotechnologies include CUTISS AG, PharmaDerm, REGENERYS LIMITED, Intercytex Ltd, ISISPHARMA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Upside Biotechnologies and CUTISS AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Upside Biotechnologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy